Hisar Intercontinental Hospital
Istanbul, 34768, Turkey (Türkiye)
NCT Number: NCT05403489
Introduction: Secondary pneumonia is frequently seen in COVID-19 cases followed up intubated, and high mortality rates can be observed. Isolation of the agent with bronchoalveolar lavage (BAL) culture or endotracheal aspirate (ETA) culture may increase the success of treatment. This study aimed to retrospectively analyze the results of BAL and ETA cultures in intubated COVID-19 cases.
Methods: We routinely apply BAL culture with bronchoscopy or ETA culture within the first 48 hours after intubating. We retrospectively screened cases who underwent BAL and ETA. They were divided into two groups: Group B and E. Evaluated parameters were compared in both groups.
Results: Demographic data and blood test results were similar in both groups. Intensive care unit (ICU) and intubation durations, and culture positivity were statistically significantly higher in Group B. Although not statistically significant, the mortality rate was higher in Group E. The most growth microorganisms were Candida species.
Conclusion: Mortality rates were consistent with the literature. Since the microorganism isolation rate is higher with BAL and antimicrobial treatment is applied more effectively; early deaths were prevented and stay periods were prolonged. In contrast, these durations were shorter in the ETA group due to higher mortality. In intubated COVID-19 cases, a more effective treatment process can be carried out by clearing the airway with fiberoptic bronchoscopy and by specifically planning the treatment according to the BAL culture. This may have a positive effect on prognosis and mortality.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Istanbul, 34768, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In cases approved for bronchoscopy, bronchoalveolar lavage was performed and culture analysis was performed.
Other names: Bronchoalveolar lavage culture, fiberoptic bronchoscopy
In cases where consent for bronchoscopy could not be obtained, tracheal secretions were aspirated and culture analysis was performed.
Time frame: 1 years
Significantly higher microbiological culture growth rate was obtained in Group B
Time frame: 1 years
Significantly higher duration of stay in intensive care unit was found in Group B
Time frame: 1 years
Significantly higher duration of stay intubated was observed in Group B
Time frame: 1 years
Mortality rate was higher in Group E. But not statistically significant.
Time frame: 1 years
The most growing microorganism in both groups was the Candida species.
Basri Cakiroglu
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06022198
Bronchoalveolar Lavage
Al Mansurah, Egypt
View Trial DetailsNCT04016480
Acute Respiratory Failure, Bronchoalveolar Lavage
Catanzaro, Italy
View Trial DetailsNCT06506617
Abnormalities, Multiple, Antimicrobial Treatment
Florence, Tuscany/Italy, Italy
View Trial DetailsNCT05077982
COVID-19, COVID-19 Pneumonia
Msida, Malta
View Trial Details